<DOC>
	<DOCNO>NCT00850837</DOCNO>
	<brief_summary>Topical microbicides , substance kill microbe , study prevent sexual transmission HIV disease pathogen . In future , topical microbicides may apply vaginally prevent acquisition transmission HIV sexually transmit infection ( STIs ) . The purpose study compare safety daily application Acidform lubricant HEC gel healthy woman low risk HIV infection ass effect microbicide candidate natural immunity woman STI pathogen .</brief_summary>
	<brief_title>Safety Acidform Lubricant HIV-Uninfected Women</brief_title>
	<detailed_description>A new approach HIV prevention currently study use topical microbicides . This study measure mucosal response daily intravaginal application Acidform lubricant HEC gel two group healthy woman low risk HIV infection . The duration study participant 3 week . Study participant randomly assign one two study group . Group 1 participant apply Acidform lubricant twice daily 14 consecutive day menses . Group 2 participant apply HEC gel 14 consecutive day menses . After screen study entry , study visit occur Days 7 , 14 , 21 . Study entry occur 2 6 day follow menses within 45 day screen . Medical sexual history , pelvic exam , cervicovaginal lavage sample collection , blood collection , vaginal pH testing , STI testing , adverse effect report occur visit . Cytobrush collection , vaginal swab , cervical biopsy occur select visit . All participant ask complete diary throughout study ; diary review study visit . A Pap smear obtain screen documentation negative Pap smear result within last year available .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Normal menstrual history regular cycle minimum 21 day menses Low risk HIV/STI infection . More information criterion find protocol . Agree abstain vaginal anal intercourse use vaginal product within 48 hour prior study entry duration study HIVinfected Menopausal Currently use hormonal contraception use hormonal contraception within 2 month study entry Menstruating screen enrollment visit Urinary tract infection screen Positive chlamydia , gonorrhea , trichomonas result screen Abnormal Pap smear Clinically detectable genital abnormality . More information criterion find protocol . Currently participate research study vaginal product History intermenstrual bleeding within 3 month prior study entry Previous gynecologic surgery receive treatment syphilis , genital herpes , chlamydia , gonorrhea , trichomonas , genital wart within 6 month prior study entry Received treatment Candida , bacterial vaginosis , urinary tract infection within 1 month prior study entry Have douche use vaginal product , include lubricant , feminine hygiene product , vaginal drying agent , sex toy within 48 hour prior study entry Vaginal anal intercourse 48 hour prior study entry Oral antibiotic within 7 day study entry Pregnant , less 6 month postpartum , breastfeed</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Microbicide</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>